Advanced glycation end products contribute to amyloidosis in Alzheimer disease - Wikidata - awgldk - TriplyDB

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

http://www.wikidata.org/entity/Q35285651

about

Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo The Rationale for Insulin Therapy in Alzheimer's Disease Transient dynamics of Aβ contribute to toxicity in Alzheimer's disease Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain Role of advanced glycation end products in cellular signaling Role of methylglyoxal in Alzheimer's disease Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling Cleavage of oxidized guanine nucleotide and ADP sugar by human NUDT5 protein Loss of CD4 T-cell-dependent tolerance to proteins with modified amino acids Immunohistochemical study of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 in the hippocampal vasculature: pathological synergy of Alzheimer's disease and diabetes mellitus The antioxidant properties of serum albumin Beyond genetic factors in familial amyloidotic polyneuropathy: protein glycation and the loss of fibrinogen's chaperone activity Molecular investigations of protriptyline as a multi-target directed ligand in Alzheimer's disease Prolonged glycation of hen egg white lysozyme generates non amyloidal structures.Differential effects of glycation on protein aggregation and amyloid formation.The sour side of neurodegenerative disorders: the effects of protein glycation.Glycation in Demetalated Superoxide Dismutase 1 Prevents Amyloid Aggregation and Produces Cytotoxic Ages Adducts.The role of ribosylated-BSA in regulating PC12 cell viability.Drugs of abuse that mediate advanced glycation end product formation: a chemical link to disease pathology Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer.Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans Selection of peptides binding to the amyloid b-protein reveals potential inhibitors of amyloid formation.Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro.Receptors for advanced glycosylation endproducts in human brain: role in brain homeostasis Evaluation of protein modification during anti-viral heat bioprocessing by electrospray ionization mass spectrometry.Neurotoxicity of advanced glycation end-products for cultured cortical neurons.Yeast protein glycation in vivo by methylglyoxal. Molecular modification of glycolytic enzymes and heat shock proteins.Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.Genetic risk factors in Alzheimer's disease Glycation and oxidation of histones H2B and H1: in vitro study and characterization by mass spectrometry.Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry.Insulin glycation by methylglyoxal results in native-like aggregation and inhibition of fibril formation Why is learning and memory dysfunction in Type 2 diabetes limited to older adults?Radix Achyranthis Bidentatae improves learning and memory capabilities in ovariectomized rats.A previously undescribed chemical link between smoking and metabolic disease Defective protein folding and aggregation as the basis of neurodegenerative diseases: the darker aspect of proteins.Glycation of the amyloid beta-protein by a nicotine metabolite: a fortuitous chemical dynamic between smoking and Alzheimer's disease.Argpyrimidine, a methylglyoxal-derived advanced glycation end-product in familial amyloidotic polyneuropathy.

P2860

Q24530141-C7087458-B096-445F-94B4-DF112418B07B Q24561776-225CDECD-2157-40E8-BBC1-32D58762DF09 Q24683214-543C9FAD-68E1-4D6A-9567-20A0ADCB1B57 Q26744834-359141FE-E9AA-4FD7-8069-61D0E71AFD58 Q26827421-ED2A0058-520A-4DD1-BC7E-B03ABB1E94FD Q27003253-016CF0F5-457D-4BF9-B06E-C5576E770687 Q27003423-937516A2-CB52-46E0-ADFC-601B0A9ACC61 Q27004644-E205571B-8A96-494D-9B42-CEE5D19356AB Q28076999-67E419B4-B884-461A-A284-8B904F8FA223 Q28115291-71299F36-B29F-4E3A-BEB6-92B295807B5A Q28243525-E4648EFB-FFF7-4901-B48B-214BAB2CBEA2 Q28269188-F4237335-EC62-4F29-84FE-6DF5E061D2BC Q28279790-9DB58BEE-A2F4-4A23-A899-3CF4AD1EF006 Q28477682-733ECFB7-E1D2-4D0F-89FB-5CDE52210954 Q28542431-448AA836-621A-4F68-B12E-2A0702AE14E4 Q30353896-7F48A094-E030-4DCE-9D7C-A16DD6E76542 Q30374807-FE759275-A2F4-422F-81C7-203150271C8C Q30386079-D58B37D2-3B2C-4CA8-8029-92F01D557627 Q30393668-4A5A2AEA-9D2A-4B47-80CC-40122AAF84E5 Q30416154-72978E64-7A2F-4C40-8C2C-B3780BF75C0F Q30434143-7B1254E5-D2F0-4EBD-99D1-08ABD026BF80 Q30476541-6B264AA6-A781-4DBB-B8E4-CBF4A2B00799 Q30575530-B5873D72-407D-409D-8231-E74F0A90B1DB Q30805913-87E4830A-E893-4858-B372-2D5C8A33B2A9 Q31111749-82751481-E3AA-4BBA-ADB4-783DB0BD3C0F Q32085442-D2A52A6A-1031-47BD-B72C-C7A992562C7C Q32163413-470AB147-7F31-4BF0-B62C-B19206D1F472 Q33181556-CB559701-41D7-4757-8955-B9C4A25AA0F4 Q33261536-75E9839C-7703-467D-9280-D936323A4035 Q33506441-E6D8E956-9DF7-4BF2-90F4-D5810526201D Q33588353-5D4A8126-7ED5-4DE6-9E76-7FA90498E11B Q33805941-70D8FCBE-E41F-4867-BA1A-01C755BDD471 Q33947437-C0634D46-A476-427F-B875-03CC617E3CE1 Q33984004-80DDA4D7-F72A-4DF1-B27A-F7CC41F108FA Q34056942-03E20B62-F722-463D-9A91-AFC67AD7AD30 Q34094560-28F804CC-0078-48D1-8C9A-23E1F3989C2A Q34156512-ECF2F452-E05A-4E27-BEF9-CD531360E1C0 Q34185176-3C0492C0-DD70-4FC4-9371-10893FD77699 Q34207086-5E4F05F2-A72C-45FE-B9F5-46B9E4FBF714 Q34336978-66227C2B-FED3-4CF3-B6F7-6500CAE5DE7E

P2860

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

http://www.wikidata.org/entity/Q35285651

description

1994 nî lūn-bûn

@nan

1994 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

@ast

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

@en

type

label

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

@ast

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

@en

prefLabel

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

@ast

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

@en

P1433

Q35285651-A5295C02-EACC-4E8C-9FC0-35D55113316C

P1476

Q35285651-152E4304-8002-4351-8030-EA57E480D990

P2093

Q35285651-5544DF97-B42B-40F3-86C4-235AF87204D6

Q35285651-8862E312-AA49-430D-806F-D5F74295F81C

Q35285651-AF5C787A-B994-4CA3-B113-1F910FA5181F

Q35285651-C2B105AC-F197-4627-8A93-0D1B06F952CF

Q35285651-C5374AB6-05F2-4294-B384-EF90DB391145

Q35285651-EB1A9640-B1D9-4BAB-B01C-E1EC7FA2C090

Q35285651-F522119A-9DEB-4989-8F57-A31ADE114A8A

Q35285651-F6555EDB-CF9B-46F2-876E-0AA979950B2F

P2860

Q35285651-011087E1-4983-4C65-8AEA-BF7AB6FD9A87

Q35285651-1C1DBAD2-BF43-41CE-BCE8-DFFFE38B6AF4

Q35285651-21B5EFF6-CCD8-4494-B438-D86EB60C1944

Q35285651-22549B66-DCD9-432E-9483-2A98D38E5825

Q35285651-4A4A2FE7-325E-4951-8079-7FC87504D206

Q35285651-4B35E3BD-2385-4363-97AA-586BDE0C0442

Q35285651-4CBF2B1E-060B-45AB-8039-C0DA3F42FDED

Q35285651-5AB802F8-2BE5-4CFD-923F-6AAC6689F984

Q35285651-73CA96A3-81D7-4DA0-92C4-6EFFF31AE1D0

Q35285651-7E23144C-D03B-4D39-8E5C-941934AD8E84

P304

Q35285651-7E17B66E-68DC-49E0-9613-F05795975D33

P31

Q35285651-5A6CC835-4FAC-44F0-9B41-7EAAC91B0A40

P356

Q35285651-57A56255-8EEF-4174-84F1-640EE5149ECE

P407

Q35285651-DDB0C94F-63D2-4093-96D5-47751FBBA780

P433

Q35285651-5903DA58-B5C9-42DE-BE71-A40E642B9077

P478

Q35285651-F3AC69DC-F00F-443C-8D95-636EDD51E379

P577

Q35285651-948C0619-7F41-4675-9981-E3BD115C7367

P5875

Q35285651-D1D7A2A3-1D80-4DB2-9904-EF237BC6E9ED

P698

Q35285651-0D83D87A-1AAA-4288-9F07-4D4FF20C718A

P921

Q35285651-1EBA55DB-1A2D-4B69-A330-DF1050105A1F

P932

Q35285651-42F01364-DB32-4239-88FE-8B4FD9AB885C

P356

PNAS.91.11.4766

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

@en

P2093

Bhattacharya K

http://www.w3.org/2001/XMLSchema#string

Bucala R

http://www.w3.org/2001/XMLSchema#string

Cerami A

http://www.w3.org/2001/XMLSchema#string

Glendening JM

http://www.w3.org/2001/XMLSchema#string

Manogue K

http://www.w3.org/2001/XMLSchema#string

Stopa E

http://www.w3.org/2001/XMLSchema#string

Vitek MP

http://www.w3.org/2001/XMLSchema#string

Vlassara H

http://www.w3.org/2001/XMLSchema#string

P2860

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking.

Nonenzymatic browning in vivo: possible process for aging of long-lived proteins.

Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production.

Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus.

A kinetic model for amyloid formation in the prion diseases: importance of seeding.

Multiple forms of beta-amyloid peptide precursor RNAs in a single cell type.

Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease.

P304

4766-4770

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.91.11.4766

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P577

1994-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15002399

http://www.w3.org/2001/XMLSchema#string

P698

8197133

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

43869

http://www.w3.org/2001/XMLSchema#string